Glenmede Trust’s Aravive, Inc. Common Stock ARAV Stock Holding History

Glenmede Trust’s Portfolio ARAV Stock Details ARAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,455	Closed	-$10	–	3153
2019 Q3	$10	Hold	1,455	–	–	﹤0.01%	2366
2019 Q2	$8	Hold	1,455	–	–	﹤0.01%	2484
2019 Q1	$10	Hold	1,455	–	–	﹤0.01%	2374
2018 Q4	$5	Buy	+1,455	New	+$8.37K	﹤0.01%	2563
2018 Q3	–	Sell	-1,457	Closed	-$18K	–	1885
2018 Q2	$18K	Hold	1,457	–	–	﹤0.01%	1748
2018 Q1	$19K	Hold	1,457	–	–	﹤0.01%	1984
2017 Q4	$19K	Hold	1,457	–	–	﹤0.01%	1984
2017 Q3	$21K	Sell	1,457 -485	-25%	-$48.9K	﹤0.01%	1954
2017 Q2	$248K	Hold	1,942	–	–	﹤0.01%	1137
2017 Q1	$248K	Buy	+1,942	New	+$205K	﹤0.01%	1137

Other funds holding ARAV

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Glenmede Trust's ARAV Position: Q4 2019 in Review

Glenmede Trust sold out of Aravive, Inc. Common Stock (ARAV) in Q4 2019, closing a stake of 1,455 shares — an estimated $10 sold.

Glenmede Trust first reported a position in ARAV in Q1 2017 and held it in 10 quarters. The position peaked at $248K in Q2 2017. 40 funds tracked by Wall St. Rank hold ARAV as of Q4 2019.

Glenmede Trust reported no remaining Aravive, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Glenmede Trust sold 1,455 Aravive, Inc. Common Stock shares in Q4 2019, an estimated $10.
Glenmede Trust first reported a position in Aravive, Inc. Common Stock in Q1 2017 and held it in 10 quarters.
Glenmede Trust's Aravive, Inc. Common Stock position peaked at $248K in Q2 2017.
40 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q4 2019.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.